Deargen
Information Technology & Services - , Daejeon, South Korea
Deargen Details
"Welcome to DEARGEN"Established in 2016 Dec., DEARGEN is an IT-BIO start-up developing a drug discovery platform by using artificial intelligence technology. DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.The members consist of diverse experts from backgrounds across Deep learning, software, biology and bioinformatics for drug discovery, these brilliant team acts faster than anyone else and consistently moves to face new challenges.Dr. UG is an AI platform for drug discovery that is based on DEARGEN's deep learning technology. It specializes in early R&D stage of Drug discovery from Target Discovery to Lead optimization. Dr.UG allows saving time and cost efficiently when compared to traditional methods.Today, DEARGEN is applying its computational platform to a develop pipeline of drug discovery programs in collaboration with pharmaceutical companies and research institute.Feb. 2020, Deargen predicted and reported drugs with high potential for treating SARS-CoV-2 using the deep-learning model, MT-DTI. The results include Remdesivir with highest potency, and others such as atazanavir, Kaletra (lopinavir/ritonavir) and hydroxychloroquine, and remdesivir, Kaletra, and hydroxychloroquine are currently on clinical study. The work is formally published on the computational and Structural Biotechnology Journal.DEARGEN was ranked in TOP Performer in the world at ‘ILSVRC2016' and ‘NCI-CPTAC DREAM Challenge' and its technology has been prove.
Deargen Technologies
Domain Name Services
Route 53
CMS
WordPress.org
Tag Management
Google Tag Manager
Hosting
Amazon AWS
Other
Mobile Friendly